For those looking for a clinically proven, long-term weight loss solution, Semaglutide stands out as one of the most effective options available today
Phase 2 trial results (48 weeks, adults with obesity): 1 mg dose: 7.2% body weight loss 4 mg dose: 12.9% body weight loss 8 mg dose: 17.3% body weight loss 12 mg dose: 24.2% body weight loss Placebo: 1.6% body weight loss Phase 3 TRIUMPH-4 results: 9 mg dose: 20.0% body weight loss (22.9 kg / 50.5 lbs) 12 mg dose: 23.7% body weight loss (27.2 kg / 60.0 lbs) Placebo: 4.6% body weight loss In a separate phase 3 analysis, retatrutide at the highest dose achieved up to 28.7% weight loss
The Future of Telehealth in Managing Chronic Conditions The potential for telehealth in managing chronic conditions like diabetes and obesity is vast
A multi-faceted approach is best: eat a diet rich in avocados, sulfurous vegetables (like broccoli), and Vitamin C
The FDA does not review compounded medications for safety, effectiveness, or quality before marketing
Time-series single-cell transcriptomic profiling of luteal-phase endometrium uncovers dynamic characteristics and its dysregulation in recurrent implantation failures